AU2002308635A1 - Antisense modulation of helicase-moi expression - Google Patents

Antisense modulation of helicase-moi expression

Info

Publication number
AU2002308635A1
AU2002308635A1 AU2002308635A AU2002308635A AU2002308635A1 AU 2002308635 A1 AU2002308635 A1 AU 2002308635A1 AU 2002308635 A AU2002308635 A AU 2002308635A AU 2002308635 A AU2002308635 A AU 2002308635A AU 2002308635 A1 AU2002308635 A1 AU 2002308635A1
Authority
AU
Australia
Prior art keywords
helicase
moi
expression
antisense modulation
antisense
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002308635A
Inventor
Donna T. Ward
Andrew T. Watt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ionis Pharmaceuticals Inc
Original Assignee
Isis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Pharmaceuticals Inc filed Critical Isis Pharmaceuticals Inc
Publication of AU2002308635A1 publication Critical patent/AU2002308635A1/en
Abandoned legal-status Critical Current

Links

AU2002308635A 2001-05-10 2002-05-07 Antisense modulation of helicase-moi expression Abandoned AU2002308635A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/853,768 2001-05-10

Publications (1)

Publication Number Publication Date
AU2002308635A1 true AU2002308635A1 (en) 2002-11-25

Family

ID=

Similar Documents

Publication Publication Date Title
AU2001289085A1 (en) Antisense modulation of flip-c expression
AU2002227435A1 (en) Antisense modulation of calreticulin expression
AU2003281327A1 (en) Antisense modulation of tfg-beta 2 expression
AU2002350228A1 (en) Antisense modulation of myd88 expression
AU2002364125A1 (en) Antisense modulation of mdm2 expression
AU2002365920A1 (en) Antisense modulation of complement component c3 expression
AU2002366788A1 (en) Antisense modulation of ship-1 expression
AU2001227847A1 (en) Antisense modulation of pepck-cytosolic expression
AU2002320525A1 (en) Antisense modulation of glioma-associated oncogene-2 expression
AU2002318139A1 (en) Antisense modulation of src-c expression
AU2002357102A1 (en) Antisense modulation of cd36l1 expression
AU2003257966A1 (en) Antisense modulation of lar expression
AU2002322551A1 (en) Antisense modulation of rip2 expression
AU2002347809A1 (en) Antisense modulation of inhibitor-kappa b kinase-gamma expression
AU2002245089A1 (en) Antisense modulation of cytohesin-1 expression
AU2003241496A1 (en) Antisense modulation of inhibitor-kappa b kinase-beta expression
AU2002319635A1 (en) Antisense modulation of short heterodimer partner-1 expression
AU2002330953A1 (en) Antisense modulation of cyclin d2 expression
AU2002357101A1 (en) Antisense modulation of cd81 expression
AU2002244086A1 (en) Antisense modulation of recql4 expression
AU2002362757A1 (en) Antisense modulation of creb expression
AU2002334599A1 (en) Antisense modulation of ksr expression
AU2002315554A1 (en) Antisense modulation of glioma-associated oncogene-3 expression
EP1578942A3 (en) ANTISENSE MODULATION OF mitoNEET EXPRESSION
AU2003295906A1 (en) ANTISENSE MODULATION OF mitoNEET EXPRESSION